Health Trials

Gastric/Gastroesophageal Junction Cancer

2

Review clinical trials related to Gastric/Gastroesophageal Junction Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors

This is a Phase 1 study intended to determine the MTD of OCT-598 following multiple-dose therapy and to establish the RP2D for OCT-598 as a single agent, by assessing its safety and tolerability as monotherapy and in combination with standard-of-care treatments in patients with advanced solid tumors.

Participants needed: 51
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Oscotec Inc.Updated: Jan 22, 2026Locations: 3
Eligibility criteria

Female or male, ≥18 years of age (or ≥19 years according to according to the loc... [+13]

Treatment with any IP or other anticancer therapy (including chemotherapy, antib... [+10]

Read more
Status: Not yet recruiting

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

This is an open-label, multicenter, Phase 1 study to evaluate the safety, tolerability, PK, and preliminary efficacy of KJ015 administered subcutaneously in participants with HER2-expressing solid tumors.

Participants needed: 66
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Bao Pharmaceuticals Co., Ltd.Updated: Jun 25, 2025Locations: 1
Eligibility criteria

Aged ≥ 18 years (at time of free and informed consent). [+5]

Concurrent participation in another clinical study. [+10]

Read more